Search Results 851-860 of 19760 for Hepatitis+C

1. A Study of the Safety and Effectiveness of TH-302 Combined with Gemcitabine and Compared with Gemcitabine Alone for Previously Untreated Patients with Pancreatic Adenocarcinoma - Mayo Clinic

   Known active infection with HIV, hepatitis B, or hepatitis C; Exhibited allergic reactions to a structural compound, biological agent, or formulation ...

2. A Study to Evaluate the Safety and Effectiveness of APT-1011 to Treat Eosinophilic Esophagitis - Mayo Clinic

   Infection with hepatitis B, hepatitis C, or human immunodeficiency virus. Have gastrointestinal bleeding or documented active peptic ulcer within 4 weeks ...

3. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

   Serologic status reflecting active hepatitis B or C infection. Patients that are positive for hepatitis B core antibody, hepatitis B surface antigen (HBsAg) ...

4. Liver transplant - Doctors & Departments - Mayo Clinic

   ... Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Primary biliary c...holangitis, Nonalcoholic fatty liver disease, Cirrhosis, Jaundice, Alcoholic hepatitis ...

5. A Study of BBI608 Combined with Standard Chemotherapies in Adult Patients who have Pancreatic Cancer - Mayo Clinic

   ... hepatitis B, or hepatitis C; History of active Peripheral Artery Disease that is treated and stable for at least 6 months. Arm B (mFOLFIRINOX) or Arm C (FOLFIRI).

6. A Study To Evaluate The Safety And Effectiveness Of The Drug TTP399 To Target A1c In Type 2 Diabetics - Mayo Clinic

   Presence of chronic active hepatitis (hepatitis B, hepatitis C, nonalcoholic steatohepatitis [NASH]) and/or known liver cirrhosis. Participation in any ...

7. Characterization Of Crohn’s Disease At A Cellular Level - Mayo Clinic

   Known hepatitis B/C; Self-reported pregnant or lactating. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...

8. Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study - Mayo Clinic

   - Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on ...

9. Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer - Mayo Clinic

   History of hepatitis C (HCV) with HCV RNA positivity within 3 months prior to the date of informed consent for this study (if no test has been performed ...

10. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    Negative hepatitis C virus (HCV) antibody or negative HCV RNA by quantitative PCR. For female subjects of childbearing potential, a negative serum pregnancy ...